Clinical Trial Update: Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating SHR0302 for efficacy and safety in adults with severe alopecia areata.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• SHR0302 (SHR0302)

Snippet

Sponsor: Reistone Biopharma Company Limited | Conditions: Alopecia Areata | Phase 3 | Status: UNKNOWN